These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3089475)

  • 1. Natural killer cells in insulin dependent diabetes mellitus.
    Wilson RG; Anderson J; Shenton BK; White MD; Taylor RM; Proud G
    Br Med J (Clin Res Ed); 1986 Jul; 293(6541):244. PubMed ID: 3089475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Natural killer cells of different immunological phenotypes (CD16+, CD56+ and CD57+) in the blood of patients with insulin-dependent diabetes mellitus].
    Shliakhovenko VS; Guzov MA; Milenko SE; Mikhaĭlovskaia EV; Kalinovskiĭ AK; Khodak AA; Zak KP
    Vrach Delo; 1991 Feb; (2):36-9. PubMed ID: 1711735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The number and ultrastructure of large granule-containing lymphocytes (natural killer cells) in the blood of patients with diabetes mellitus type 1].
    Zak KP; Khomenko BM; Afanas'eva VV; Sakalo EA
    Probl Endokrinol (Mosk); 1987; 33(4):3-5. PubMed ID: 3658946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of insulin therapy on the level of natural killer cells of different immunological phenotypes (CD16+, CD56+ and CD57+) in the blood of patients with diabetes mellitus type I].
    Gruzov MA; Shliakhovenko VS; Zak KP; Efimov AS; Kalinovskiĭ AK; Mikhaĭlovsksia EV; Sliusarenko NS
    Lik Sprava; 1992 Aug; (8):60-2. PubMed ID: 1282283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphocyte immunophenotype in children with diabetes mellitus type I during long-term insulin therapy].
    Zak KP; Malynovs'ka TM; Hruzov MA
    Lik Sprava; 2001; (3):44-7. PubMed ID: 11560025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological studies on insulin-dependent diabetes mellitus (IDDM). I. Natural killer (NK) cell activity].
    Tomoda T; Hamada F; Zushi N; Kurashige T; Kitamura I; Kunitomi T
    Arerugi; 1987 Mar; 36(3):162-8. PubMed ID: 3300607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cellular immunity in diabetes mellitus].
    Barañao RI; Rumi LS
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):7-11. PubMed ID: 6083584
    [No Abstract]   [Full Text] [Related]  

  • 8. [The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II].
    Salozhin KV; Sura VV; Nasonov EL; Korneeva MN; Smirnova OI
    Ter Arkh; 1989; 61(10):104-6. PubMed ID: 2609254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin therapy corrects NK cells abnormality in type I diabetes mellitus patients.
    Guastafierro S; Sessa F; Cerciello T; Cuomo C; Giannetti G
    Biomed Pharmacother; 1996; 50(1):38-9. PubMed ID: 8672733
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrastructure of lymphocyte subsets and of activated lymphocytes in type 1 diabetes as defined by monoclonal antibodies and the immunogold technique.
    Lampeter EF; Krug J; Beales P; Sutherland J; Cossel L; Pozzilli P
    Diabetes Res; 1987 Jun; 5(2):59-66. PubMed ID: 3652617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 12. Altered immunity and diabetes in the BB rat.
    Yale JF; Marliss EB
    Clin Exp Immunol; 1984 Jul; 57(1):1-11. PubMed ID: 6378457
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-specific cellular immunity in type I and type II diabetes.
    Fövenyi J; Tótpál K; Thaisz E; Garam T
    Exp Clin Endocrinol; 1984 Apr; 83(2):203-6. PubMed ID: 6539221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cellular immunity in patients with newly detected insulin-dependent diabetes mellitus].
    Dedov II; Chugunova LA; Smirnova OM; Brykova SV; Shchegol'kova TS
    Probl Endokrinol (Mosk); 1994; 40(1):17-20. PubMed ID: 8165207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural killer (NK) cells and T-lymphocytes in the peripheral blood of Behçet's disease].
    Uchiyama M; Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Ryumachi; 1986 Feb; 26(1):2-9. PubMed ID: 3487126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibody-mediated cytotoxic activity off circulating lymphocytes directed against human red blood cells in type I and type II diabetes].
    Fövényi J; Garam T; Tótpál K; Thaisz E; Bakács T
    Orv Hetil; 1983 Jun; 124(26):1547-9. PubMed ID: 6604250
    [No Abstract]   [Full Text] [Related]  

  • 17. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
    Spooren PF; Vermes I; Soons JW
    Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.
    Fraker C; Bayer AL
    Curr Diab Rep; 2016 Nov; 16(11):109. PubMed ID: 27664042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis.
    Kumar NP; Sridhar R; Nair D; Banurekha VV; Nutman TB; Babu S
    Immunology; 2015 Apr; 144(4):677-86. PubMed ID: 25363329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.
    Nakata S; Imagawa A; Miyata Y; Yoshikawa A; Kozawa J; Okita K; Funahashi T; Nakamura S; Matsubara K; Iwahashi H; Shimomura I
    Immunol Lett; 2013; 156(1-2):149-55. PubMed ID: 24177169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.